A new report shares Britest's experience of the challenges presented by COVID-19 lockdown restrictions along with an analysis of significant benefits quantified in terms of time, money, and emissions saved, and new possibilities created by successfully harnessing remote working and service delivery.
Dr. Silvia Tedesco of Manchester Metropolitan University explains how the InnovateUK funded proof of concept project is exploring the feasibility of turning a significant industrial process side stream - paper mill sludge - into the strategically important platform chemical Levulinic Acid.
A new 2-minute-to-watch video explains how Britest's roadmap for digital design development and application can be used by organisations in the chemicals-using and process industries to successfully plan for a rapid and effective business introduction of new ways of working based upon emerging digital and modelling based process design, development and control methods.
Britest Limited has entered into a licensing agreement with Micropore Technologies. This allows Micropore to use a defined set of Britest’s established process understanding tools, in conjunction with their own proprietary technologies, to support their internal evaluation of potential applications of their membrane emulsification and encapsulation technology for client demonstration and general marketing purposes.
Article on digital information flows goes open access A new publication describing how new digital models and approaches have been mapped onto the information workflow involved in pharmaceutical product and process design and development via a Britest-developed dedicated technical
A new "task library" supporting the use of the Britest Process Definition Diagram (PDD) tool substantially expands the armoury of ready-made task representations available to Britest facilitators and practitioners, and helps create better PDDs faster.
A dedicated technical facilitation process designed and delivered by Britest has enabled a the development of an information flow for digital design and manufacture of pharmaceuticals which is set to .be a valuable enabler for the UK pharmaceutical industry in adopting new technology, and in building innovation and leadership capacity